Literature DB >> 6201004

A genetic marker of human IgE heavy chains, Em(1).

E van Loghem, R C Aalberse, H Matsumoto.   

Abstract

A monoclonal anti-IgE antibody was obtained that reacted with some IgE myeloma proteins and with all but a few normal sera. Family studies proved that a genetic marker of IgE had been detected. This allotype, called Em(1), segregates in association with certain Gm-Am haplotypes. The available quantitative evidence warrants the conclusion that human IgE has genetic variants, but no subclasses. Samples from various populations of five continents, representative for the respective prevalent Gm-Am haplotypes, were tested for Em(1). Em(1) was absent mainly in haplotypes carrying A2m(2) and G2m(n). These closely linked genes are located in a chromosomal region that comprises the gamma 2-gamma 4-epsilon-alpha 2 CH genes. A hypothesis for the generation of Em(1) is given.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6201004     DOI: 10.1111/j.1423-0410.1984.tb00075.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  8 in total

Review 1.  Clinical significance of anti-IgE autoantibodies and immune complexes containing IgE.

Authors:  C G Magnusson; S G Johansson
Journal:  Clin Rev Allergy       Date:  1989

Review 2.  Characteristics of Mongoloid and neighboring populations based on the genetic markers of human immunoglobulins.

Authors:  H Matsumoto
Journal:  Hum Genet       Date:  1988-11       Impact factor: 4.132

3.  BamHI and SacI RFLPs of the human immunoglobulin IGHG genes with reference to the Gm polymorphism in African people. Evidence for a major polymorphism.

Authors:  N Ghanem; M Bensmana; J M Dugoujon; J Constans; M P Lefranc; G Lefranc
Journal:  Hum Genet       Date:  1989-08       Impact factor: 4.132

4.  A multigene deletion within the immunoglobulin heavy-chain region.

Authors:  H Chaabani; N T Bech-Hansen; D W Cox
Journal:  Am J Hum Genet       Date:  1985-11       Impact factor: 11.025

5.  Mechanism of resistance to cetuximab therapy in colorectal cancer: Possible role of antibodies to immunoglobulin allotypes.

Authors:  Janardan P Pandey
Journal:  MAbs       Date:  2012-07-23       Impact factor: 5.857

Review 6.  Sagacious epitope selection for vaccines, and both antibody-based therapeutics and diagnostics: tips from virology and oncology.

Authors:  Samuel Ken-En Gan; Ser-Xian Phua; Joshua Yi Yeo
Journal:  Antib Ther       Date:  2022-02-21

7.  The eIg technology to generate Ig-like bispecific antibodies.

Authors:  Lennart Kühl; Nadine Aschmoneit; Roland E Kontermann; Oliver Seifert
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 6.440

Review 8.  Beyond Allotypes: The Influence of Allelic Diversity in Antibody Constant Domains.

Authors:  Annmaree K Warrender; William Kelton
Journal:  Front Immunol       Date:  2020-08-18       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.